PF-05231023, an FGF21 analog, was reported to have beneficial effects on body weight, lipoprotein profile, and adiponectin concentrations in overweight/obese subjects with type 2 diabetes (50). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.